Caitriona O’Driscoll is Professor and Chair of Pharmaceutics in the School of Pharmacy in UCC. She completed her PhD studies in Pharmaceutical Sciences in Trinity College Dublin (TCD) and undertook a sabbatical in the Department of Pharmaceutical Chemistry at the University of Kansas, USA. She was a senior lecturer in the School of Pharmacy at TCD prior to her appointment to UCC in 2003. She is a Board member of the Health Products Regulatory Authority, and the Critical Path Institute. She is a founding member and Chair of Regulatory Science Ireland.
Professor O’Driscoll’s research interests are translational in nature and include formulation of nano-sized drug delivery constructs, which remain stable during processing and storage, and are safe and effective for use by patients. Candidate drugs include biopharmaceuticals, peptide/proteins, nucleic acids and poorly water-soluble compounds. Delivery systems of interest are; lipid-based vehicles and non-viral gene delivery systems employing modified cyclodextrins, nanoparticles and receptor-ligand mediated targeting.
- Nano-sized drug delivery
- Nucleic acids
- Poorly water-soluble compounds
- Lipid-based vehicles
- Non-viral gene delivery systems
- Modified cyclodextrins
- Receptor-ligand mediated targeting